Hep­tares co-founder Fiona Mar­shall grabs the helm at Mer­ck­'s up­com­ing UK drug dis­cov­ery cen­ter

 

In a boost to its planned $1.3 bil­lion UK drug re­search hub and head­quar­ters, Mer­ck an­nounced to­day that it has re­cruit­ed the not­ed British sci­en­tist and biotech ex­ec Fiona Mar­shall to the top job at the cen­ter, which is ex­pect­ed to open in Lon­don in 2020.

The Hep­tares co-founder re­signed from the EVP and CSO po­si­tions at par­ent com­pa­ny So­sei last week, mak­ing waves in the G pro­tein-cou­pled re­cep­tors-tar­get­ing biotech that she helped cre­ate more than 10 years ago. An ex­pert in GPCR bi­ol­o­gy, Mar­shall led the first group to show that GPCRs could form het­erodimers and has played ad­vi­so­ry roles in re­search or­ga­ni­za­tions such as Alzheimer’s Re­search UK and Fran­cis Crick In­sti­tute.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.